Breaking News

Avalon GloboCare Forms Strategic CAR-T Pact

Aims to co-develop bio-production and standardization procedures for CAR-T therapy in accordance with standards

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Avalon GloboCare Corp. has formed a strategic partnership with Weill Cornell’s cGMP Cellular Therapy Facility and Lab for Advanced Cellular Engineering headed by Dr. Yen-Michael Hsu. The partnership aims to co-develop bio-production and standardization procedures in procurement, storage, processing, clinical study protocols, and bio-banking for Chimeric Antigen Receptor (CAR)-T therapy, in accordance with the Foundation of Accreditation for Cellular Therapy (FACT) and American Association of Blo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters